Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 1133-1137

  Brace, Chantalle ^a   Gloor, Gregory B ^b   Ropeleski, Mark ^a   Allen Vercoe, Emma ^c   Petrof, Elaine O ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

Clostridium difficile; Fecal bacteriotherapy; Fecal microbiota transplantation; Gut microbiome; Inflammatory bowel disease; Probiotics; Ulcerative colitis

Indexed keywords

BUDESONIDE; CEFALEXIN; CEFPROZIL; CEFUROXIME; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ENEMA; MESALAZINE; METRONIDAZOLE; MOXIFLOXACIN; PROBIOTIC AGENT; SODIUM CHLORIDE; VANCOMYCIN;

ABDOMINAL PAIN; ACTINOBACTERIA; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASCENDING COLON; BACILLI; BACTEROIDETES; BLOODY DIARRHEA; CASE REPORT; CECUM; CELL INFILTRATION; CELLULITIS; CLOSTRIDIA; CLOSTRIDIUM DIFFICILE INFECTION; COLON LAVAGE; COLONOSCOPY; DISEASE DURATION; ENTEROBACTERIACEAE; FECAL MICROBIOTA TRANSPLANTATION; FECES COMPOSITION; FECES CULTURE; FECES MICROFLORA; FEMALE; FIRMICUTES; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; INFLAMMATORY BOWEL DISEASE; LYMPHOCYTIC INFILTRATION; MAINTENANCE THERAPY; MICROBIOME; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; PLASMA CELL; PRIORITY JOURNAL; PROTEOBACTERIA; RECTUM HEMORRHAGE; RECTUM MUCOSA; RECTUM ULCER; RECURRENT DISEASE; REMISSION; SIGMOIDOSCOPY; SPECIES COMPOSITION; SPECIES DOMINANCE; TRANSVERSE COLON; TREATMENT DURATION; ULCERATIVE COLITIS; VERY ELDERLY; WEIGHT REDUCTION; FECES ANALYSIS; PEPTOCLOSTRIDIUM DIFFICILE; TRANSPLANTATION; COLITIS, ULCERATIVE; COMPLICATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MICROFLORA;

AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; COLITIS, ULCERATIVE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; HUMANS; MALE; MICROBIOTA; SIGMOIDOSCOPY;

EID: 84906791963     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.020     Document Type: Article

References (16)

1. Clayton E.M., Rea M.C., Shanahan F., Quigley E.M., Kiely B., Hill C., et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009, 104:1162-1169.
2. Nguyen G.C., Kaplan G.G., Harris M.L., Brant S.R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:1443-1450.
3. Berg A.M., Kelly C.P., Farraye F.A. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013, 19:194-204.
4. Reddy S.S., Brandt L.J. Clostridium difficile infection and inflammatory bowel disease. J Clin Gastroenterol 2013, 47:666-671.
5. Gough E., Shaikh H., Manges A.R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011, 53(10):994-1002.
6. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoentendal G., de Vos W.M.K., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368(5):407-415.
7. Kassam Z., Lee C.H., Yuan Y., Hunt R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013, 108:500-508.
8. Anderson J.L., Edney R.J., Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012, 36:503-516.
9. De Leon L.M., Watson J.B., Kelly C.R. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2013, 11:1036-1038.
10. Shahinas D., Silverman M., Sittler T., Chiu C., Kim P., Allen-Vercoe E., et al. Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene sequencing. mBio 2012, 3(5):e00338-12.
11. Khoruts A., Dicksved J., Jansson J.K., Sadowsky M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2009, 00(00).
12. Bakken J.S. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009, 15:285-289.
13. Petrof E.O., Gloor G.B., Vanner S.J., Weese S.J., Carter D., Daigneault M.C.A., et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'rePOOPulating' the gut. Microbiome 2013, 1(3).
14. Faith J.J., Guruge J.L., Charbonneau M., Subramanian S., Seedorf H., Goodman A.L.G., et al. The long-term stability of the human gut microbiota. Science 2013, 341(6141).
15. Kump P.K., Grochenig H.P., Lackner S., Trajanoski S., Reicht G., Hoffman K.M, et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013, 19:2155-2165.
16. Angelberger S., Reinisch W., Makristathis A., et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013, 108:1620-1630.